Ken Griffin Apyx Medical Corp Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Apyx Medical Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 23,100 shares of APYX stock, worth $38,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,100

Previous 66,355 65.19%

Holding current value

$38,115

Previous $104,000 70.19%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.0 - $1.72 $52,789 - $90,797	-52,789 Reduced 79.56%	13,566 $18,000
Q4 2024 Feb 14, 2025	BUY	$1.1 - $1.9 $59,160 - $102,185	53,782 Added 427.76%	66,355 $104,000
Q3 2024 Nov 14, 2024	BUY	$1.01 - $1.46 $9,389 - $13,573	9,297 Added 283.79%	12,573 $15,000
Q2 2024 Aug 14, 2024	BUY	$1.26 - $1.66 $4,127 - $5,438	3,276 New	3,276 $4,000
Q4 2023 Feb 14, 2024	BUY	$1.49 - $3.25 $67,540 - $147,319	45,329 Added 313.57%	59,785 $156,000
Q3 2023 Nov 14, 2023	BUY	$3.07 - $6.2 $36,198 - $73,104	11,791 Added 442.44%	14,456 $46,000
Q2 2023 Aug 14, 2023	SELL	$2.75 - $7.59 $305,712 - $843,765	-111,168 Reduced 97.66%	2,665 $13,000
Q1 2023 May 15, 2023	BUY	$2.45 - $3.59 $94,516 - $138,495	38,578 Added 51.26%	113,833 $327,000
Q4 2022 Feb 14, 2023	BUY	$1.4 - $5.02 $82,990 - $297,580	59,279 Added 371.05%	75,255 $176,000
Q3 2022 Nov 14, 2022	SELL	$4.49 - $10.83 $355,410 - $857,259	-79,156 Reduced 83.21%	15,976 $72,000
Q2 2022 Aug 15, 2022	BUY	$3.11 - $7.5 $295,860 - $713,490	95,132 New	95,132 $557,000
Q1 2022 May 16, 2022	SELL	$5.87 - $13.13 $188,098 - $420,737	-32,044 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$12.15 - $17.4 $215,322 - $308,362	-17,722 Reduced 35.61%	32,044 $410,000
Q3 2021 Nov 15, 2021	SELL	$8.79 - $13.96 $115,483 - $183,406	-13,138 Reduced 20.89%	49,766 $689,000
Q2 2021 Aug 16, 2021	BUY	$9.02 - $10.83 $379,480 - $455,628	42,071 Added 201.94%	62,904 $648,000
Q1 2021 May 17, 2021	BUY	$6.91 - $11.81 $143,956 - $246,037	20,833 New	20,833 $202,000
Q2 2020 Aug 14, 2020	SELL	$2.87 - $5.83 $59,911 - $121,701	-20,875 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.24 - $8.51 $67,635 - $177,646	20,875 New	20,875 $75,000
Q2 2019 Aug 14, 2019	SELL	$3.64 - $6.95 $66,251 - $126,496	-18,201 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$6.31 - $8.75 $114,848 - $159,258	18,201 New	18,201 $0

Others Institutions Holding APYX

# of Institutions

Shares Held

17.4M

Call Options Held

60.3K

Put Options Held

View Full List

About Apyx Medical Corp

Ticker APYX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 34,573,000
Market Cap $57M
Description
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...

More about APYX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account